Charles W. Newton - 09 Mar 2026 Form 3 Insider Report for Keros Therapeutics, Inc. (KROS)

Role
Director
Signature
/s/ Esther Cho, Attorney-in-Fact
Issuer symbol
KROS
Transactions as of
09 Mar 2026
Net transactions value
$0
Form type
3
Filing time
11 Mar 2026, 16:37:23 UTC
Previous filing
22 Aug 2025

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Newton Charles W. Director C/O KEROS THERAPEUTICS, INC., 1050 WALTHAM STREET, SUITE 302, LEXINGTON /s/ Esther Cho, Attorney-in-Fact 11 Mar 2026 0001866219

No securities are beneficially owned.